Liu et al., 2014), a novel dimeric form of the K1 domain, designated K1K1 (Vallarola et al., 2020), the semi-synthetic engineered K1 domain, designed to be multimer by biotin-avidin interaction (Simonneau et al., 2015), a MET-agonistic DNA aptamer (Ueki et al., 2016, 2020), and MET-agonistic synthetic macrocyclic peptides (Sato et al., 2020)
See our full FAQ page for 25+ questions
Many advanced routines use both, just not necessarily in the same session, especially when using a micro-infusion or microneedling-style tool
LJ SYNERGY TERMS AND CONDITIONS OF SALE By placing orders and making payment, you have read and accepted all terms and conditions
Fiscal tools, in particular, represent a promising yet underexplored approach in planning literature